HESI Cardiac Safety Early Career Webinar Series – Louise Hesketh

The Cardiac Safety Steering Team is proud to present the second webinar series featuring the 2023 Early Career Seminar Series Awardees.  This competitive award is given to postdoctoral or early career scientists who have compelling research related to cardiovascular safety and risk assessment.

Three awardees were selected for the 2023 Seminar Series:

1. Loukia Yiangou, Leiden University Medical Center (April 28th @10am EDT)
2. Louise Hesketh, King's College London (May 19th @10am EDT)
3. Catherine Garrison, BMS (TBD)

Utilising the prodrug concept and translational ex vivo animal models to assess and improve the therapeutic index of antiarrhythmic drugs

Speaker Bio: Dr. Louise Hesketh is a postdoctoral research associate at King’s College London in the School of Cardiovascular and Metabolic Medicine and Sciences. She started at King’s as an undergraduate in 2013, receiving her BSc in Biomedical Sciences in 2016, before remaining to complete her PhD in Cardiovascular Sciences under the supervision of Dr. Michael Curtis. After her PhD, Louise then returned to King’s in 2022 to undertake a 3-year postdoctoral research associate role alongside Dr. Curtis, after the lab obtained a project grant award from the British Heart Foundation. Throughout her time at King’s, Louise’s research has focused on investigating ischaemia-activated antiarrhythmic prodrugs, developed to abolish the risk of off-target adverse effects resulting from the pharmacological treatment of ventricular arrhythmias caused by acute ischaemia. Her research methods primarily involve utilising translational ex vivo and in vivo animal models of myocardial ischaemia to assess the antiarrhythmic effectiveness and safety of antiarrhythmic drugs, in tandem, to obtain an estimate of their therapeutic index.

For webinar link contact: HESI Cardiac Safety cardiacsafety@hesiglobal.org